Tempus ECG-Low EF vs Steth IO
AI Verdict
Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if your primary goal is to leverage AI for automated, early identification of patients aged 40 or older at risk of heart failure directly from standard 12-lead ECGs. This tool is ideal for integrating into existing clinical diagnostic workflows to flag potential low LVEF cases for further evaluation, streamlining risk assessment.
View Tempus ECG-Low EF →Choose Steth IO if…
Choose Steth IO if you require a versatile, mobile solution to enhance physical examinations, facilitate telemedicine, and enable remote patient monitoring through advanced auscultation. This tool is best suited for healthcare providers who need to visualize, record, and securely share heart and lung sounds in real-time, improving diagnostic accuracy and specialist collaboration across various care settings.
View Steth IO →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-Low EF | Steth IO |
|---|---|---|
| Pricing | Unknown | Customized pricing; subscription-based for steth io spot. |
| Deployment | Integrates with current ECG platforms and electronic health records (EHRs). | Mobile app, Cloud-based system. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Tempus ECG-Low EFTempus ECG-Low EF integrates seamlessly into existing healthcare facility workflows and EHR systems, operating without a dedicated user interface and providing a simple binary output. This 'behind-the-scenes' operation minimizes the learning curve and disruption for clinicians, making it highly usable within established clinical practices.
Clinical Value
Tempus ECG-Low EFTempus ECG-Low EF offers significant clinical value by using AI to detect signs of low LVEF from routine 12-lead ECGs, a condition traditionally requiring echocardiography. This predictive capability enables earlier identification of patients at risk for heart failure, potentially leading to timely interventions.
Pricing & Value
Steth IOSteth IO provides more transparent pricing options, including a subscription-based model for Steth IO Spot with a clear monthly cost and included services. In contrast, Tempus ECG-Low EF's pricing is listed as 'contact vendor,' which offers no immediate insight into its cost-effectiveness.
Enterprise Readiness
Tempus ECG-Low EFTempus ECG-Low EF demonstrates superior enterprise readiness with explicit HIPAA compliance and a Business Associate Agreement (BAA), alongside a strong focus on seamless EHR integration. Its large training dataset and dedicated platform for managing tests and results further underscore its scalability and reliability for large-scale deployment.
Innovation
Tempus ECG-Low EFTempus ECG-Low EF is highly innovative for leveraging AI to extract predictive insights for low LVEF from standard, readily available 12-lead ECGs, a condition typically requiring more advanced imaging. This represents a disruptive approach to early disease detection within cardiology. Steth IO innovates the traditional stethoscope, but Tempus's AI-driven predictive analytics from existing data is a more fundamental shift in diagnostic methodology.
Support & Docs
Tempus ECG-Low EFTempus AI provides clearly defined customer support channels, including phone and email, with specified hours of operation for their customer service team. While Steth IO offers user guides and email support, Tempus's broader corporate infrastructure suggests a more established and accessible support system.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-Low EF | Steth IO |
|---|---|---|
| Name | Tempus ECG-Low EF | Steth IO |
| Company | Tempus AI | STRATOSCIENTIFIC |
| Primary Function | AI software analyzing 12-lead ECGs to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) | Smartphone stethoscope for hearing, visualizing, recording, and sharing heart and lung sounds |
| Key Data Analyzed | 12-lead ECG recordings | Heart and lung sounds (phonocardiogram/spectrogram) |
| Target Patient Population/Age | Patients 40 years or older at risk of heart failure | Not specified |
| Specialties | Cardiology, Emergency Medicine, Internal Medicine | Cardiology, Internal Medicine, Pulmonology |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-Low EF and Steth IO.
More Comparisons
More matchups featuring Tempus ECG-Low EF or Steth IO
Backers
Who funded each tool's parent company.